ARTICLE | Clinical News
Sepranolone: Preliminary Phase II data
June 16, 2014 7:00 AM UTC
Umecrine's Umecrine Mood AB subsidiary reported preliminary data from an exploratory, double-blind, Swedish Phase II trial in 120 patients with PMDD showing that subcutaneous UC1010 missed the primary...